Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Differentiated Thyroid Cancer: full-pipeline trial registry
3 of 6 indexed Differentiated Thyroid Cancer trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Differentiated Thyroid Cancer: 6 US clinical trials tracked, 3 recruiting.
Differentiated Thyroid Cancer is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital of Philadelphia, running 3 of these trials.
Enrollment posture brief
Registry condition differentiated-thyroid-cancer
OPEN 3 | RECR 50% | LATE 2 | EARLY 3 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Differentiated Thyroid Cancer lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Differentiated Thyroid Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Differentiated Thyroid Cancer is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Differentiated Thyroid Cancer research.
Children's Hospital of Philadelphia accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Differentiated Thyroid Cancer trials plan to enrol fewer than 100 people.
Median target enrolment is 32 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Differentiated Thyroid Cancer research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Children's Hospital of Philadelphia
NCT05024929
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Children's Hospital of Philadelphia
NCT06458036
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
NCT05783323
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
Exelixis
NCT03690388
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
Massachusetts Eye and Ear Infirmary
NCT04321954
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Genzyme, a Sanofi Company
NCT01876784
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Differentiated Thyroid Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Differentiated Thyroid Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Differentiated Thyroid Cancer page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Differentiated Thyroid Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospital of Philadelphia sponsors the most Differentiated Thyroid Cancer trials on record, review their full trial history before evaluating a specific study. See Children's Hospital of Philadelphia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Differentiated Thyroid Cancer condition card totals 6 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.